BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22948883)

  • 1. Identification of hepatitis C virus inhibitors targeting different aspects of infection using a cell-based assay.
    Yu X; Sainz B; Petukhov PA; Uprichard SL
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6109-20. PubMed ID: 22948883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a cell-based hepatitis C virus infection fluorescent resonance energy transfer assay for high-throughput antiviral compound screening.
    Yu X; Sainz B; Uprichard SL
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4311-9. PubMed ID: 19620334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel anti-hepatitis C virus agents by a quantitative high throughput screen in a cell-based infection assay.
    Hu Z; Hu X; He S; Yim HJ; Xiao J; Swaroop M; Tanega C; Zhang YQ; Yi G; Kao CC; Marugan J; Ferrer M; Zheng W; Southall N; Liang TJ
    Antiviral Res; 2015 Dec; 124():20-9. PubMed ID: 26515788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel cell-based hepatitis C virus infection assay for quantitative high-throughput screening of anti-hepatitis C virus compounds.
    Hu Z; Lan KH; He S; Swaroop M; Hu X; Southall N; Zheng W; Liang TJ
    Antimicrob Agents Chemother; 2014; 58(2):995-1004. PubMed ID: 24277038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-based hepatitis C virus infection fluorescence resonance energy transfer (FRET) assay for antiviral compound screening.
    Yu X; Uprichard SL
    Curr Protoc Microbiol; 2010 Aug; Chapter 17(1):Unit 17.5.. PubMed ID: 20812217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Throughput Screening, Discovery, and Optimization To Develop a Benzofuran Class of Hepatitis C Virus Inhibitors.
    He S; Jain P; Lin B; Ferrer M; Hu Z; Southall N; Hu X; Zheng W; Neuenswander B; Cho CH; Chen Y; Worlikar SA; Aubé J; Larock RC; Schoenen FJ; Marugan JJ; Liang TJ; Frankowski KJ
    ACS Comb Sci; 2015 Oct; 17(10):641-52. PubMed ID: 26332742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from
    Sahuc ME; Sahli R; Rivière C; Pène V; Lavie M; Vandeputte A; Brodin P; Rosenberg AR; Dubuisson J; Ksouri R; Rouillé Y; Sahpaz S; Séron K
    J Virol; 2019 May; 93(10):. PubMed ID: 30842319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel small molecule inhibitors against the NS3/4A protease of hepatitis C virus genotype 4a.
    El-Sayed SM; Ali MAM; El-Gendy BEM; Dandash SS; Issac Y; Saad R; Azab MM; Mohamed MR
    Curr Pharm Des; 2018; 24(37):4484-4491. PubMed ID: 30501598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cell-based, high-throughput screen for small molecule regulators of hepatitis C virus replication.
    Kim SS; Peng LF; Lin W; Choe WH; Sakamoto N; Kato N; Ikeda M; Schreiber SL; Chung RT
    Gastroenterology; 2007 Jan; 132(1):311-20. PubMed ID: 17241881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of hepatitis C virus infection by hydroxyzine and benztropine.
    Mingorance L; Friesland M; Coto-Llerena M; Pérez-del-Pulgar S; Boix L; López-Oliva JM; Bruix J; Forns X; Gastaminza P
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3451-60. PubMed ID: 24709263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives.
    Nakajima S; Watashi K; Kamisuki S; Tsukuda S; Takemoto K; Matsuda M; Suzuki R; Aizaki H; Sugawara F; Wakita T
    Biochem Biophys Res Commun; 2013 Nov; 440(4):515-20. PubMed ID: 24099774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel small-molecule inhibitors of hepatitis C virus entry block viral spread and promote viral clearance in cell culture.
    Coburn GA; Fisch DN; Moorji SM; de Muys JM; Murga JD; Paul D; Provoncha KP; Rotshteyn Y; Han AQ; Qian D; Maddon PJ; Olson WC
    PLoS One; 2012; 7(4):e35351. PubMed ID: 22545104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver-specific mono-unsaturated fatty acid synthase-1 inhibitor for anti-hepatitis C treatment.
    Nio Y; Hasegawa H; Okamura H; Miyayama Y; Akahori Y; Hijikata M
    Antiviral Res; 2016 Aug; 132():262-7. PubMed ID: 27392483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus complete life cycle screen for identification of small molecules with pro- or antiviral activity.
    Gentzsch J; Hinkelmann B; Kaderali L; Irschik H; Jansen R; Sasse F; Frank R; Pietschmann T
    Antiviral Res; 2011 Feb; 89(2):136-48. PubMed ID: 21167208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 25-Hydroxyvitamin D3 suppresses hepatitis C virus production.
    Matsumura T; Kato T; Sugiyama N; Tasaka-Fujita M; Murayama A; Masaki T; Wakita T; Imawari M
    Hepatology; 2012 Oct; 56(4):1231-9. PubMed ID: 22487892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Class of Small Molecule Compounds that Inhibit Hepatitis C Virus Infection by Targeting the Prohibitin-CRaf Pathway.
    Liu S; Wang W; Brown LE; Qiu C; Lajkiewicz N; Zhao T; Zhou J; Porco JA; Wang TT
    EBioMedicine; 2015 Nov; 2(11):1600-6. PubMed ID: 26870784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypes of hepatitis C virus in relapsed and non-respondent patients and their response to anti-viral therapy in district Mardan, Khyber Pakhtunkhawa, Pakistan.
    Akhtar N; Bilal M; Rizwan M; Khan MA; Khan A
    Asian Pac J Cancer Prev; 2015; 16(3):1037-40. PubMed ID: 25735327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel small-molecule inhibitor of hepatitis C virus replication acts by suppressing signal transducer and activator of transcription 3.
    Niu Y; Si Y; Li Y; Chi X; Li X; Liu X; Li D; Cheng M; Fan J; Si S; Yang W
    J Antimicrob Chemother; 2015 Jul; 70(7):2013-23. PubMed ID: 25858355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robust antiviral efficacy upon administration of a nucleoside analog to hepatitis C virus-infected chimpanzees.
    Carroll SS; Ludmerer S; Handt L; Koeplinger K; Zhang NR; Graham D; Davies ME; MacCoss M; Hazuda D; Olsen DB
    Antimicrob Agents Chemother; 2009 Mar; 53(3):926-34. PubMed ID: 19075052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico identification, design and synthesis of novel piperazine-based antiviral agents targeting the hepatitis C virus helicase.
    Bassetto M; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; Courtney-Smith M; Brancale A
    Eur J Med Chem; 2017 Jan; 125():1115-1131. PubMed ID: 27810598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.